Clover Health Investments (CLOV) Operating Expenses (2019 - 2026)

Clover Health Investments' Operating Expenses history runs 8 years deep, the most recent figure standing at $721.9 million for Q1 2026.

• Quarterly Operating Expenses rose 55.7% year-over-year to $721.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 billion (up 50.12% YoY) and the FY2025 annual result came in at $2.0 billion, up 41.85% from the prior year.
• Operating Expenses was $721.9 million for Q1 2026 at Clover Health Investments, up from $537.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $961.9 million in Q1 2022 and bottomed at -$1.5 billion in Q4 2022.
• A 5-year average of $411.6 million and a median of $401.7 million in 2023 frame the typical range for Operating Expenses.
• Peak annual rise in Operating Expenses reached 201.13% in 2022, while the deepest fall reached 335.77% in 2022.
• Clover Health Investments' Operating Expenses stood at -$1.5 billion in 2022, then soared by 125.74% to $375.5 million in 2023, then decreased by 4.56% to $358.4 million in 2024, then soared by 49.84% to $537.0 million in 2025, then jumped by 34.42% to $721.9 million in 2026.
• Business Quant data shows CLOV's Operating Expenses at $721.9 million in Q1 2026, $537.0 million in Q4 2025, and $521.0 million in Q3 2025.